ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Considering that obesity, T2D, and NAFLD share insulin resistance as a common pathophysiologic mechanism20 and that the dominant expression of betatrophin is in human liver12, we hypothesized that circulating betatrophin levels might be elevated in subjects with NAFLD.